7 months after the detonation of the shares, the group terminated the directional additional

7 months ago, just replaced the actual control of the Chinese god Group soon (000790, closing price of 17.24 Yuan) announced a 32 million-share directional issuance plan, detonated after the market for the shares of frenzied pursuit. China God group from the then 10 yuan below, all the way to the highest 27.51 yuan, the rise of more than 150%, even with yesterday (January 27) The closing price, the rise of 60%.　　But yesterday, the group announced abruptly that the company decided to terminate the issue because of uncertainty over the conditions for non-public offerings. 7 months after the sudden termination of the new issue last June 5, the Chinese god Group announced that the proposed to the specific object of the non-public offering of not more than 32 million shares, raising capital of 275 million yuan for the Chinese god Group Pharmaceutical plant technical transformation and expansion and new drug research and development projects, Watson's biological technology extension and Licatin in-depth research The bio-Technical renovation extension project and 37 planting base construction and reserve project.　　Among them, the Hua Shen Group of pharmaceutical companies and new drug research and development projects are expected to invest 135 million yuan, the other three projects are expected to invest 65 million yuan, 45 million yuan and 30 million yuan respectively.　　News released, the company's share price began a round of crazy rally, even in June last year, July, the collective plunge in pharmaceutical stocks, the Chinese god Group is still strong, as the weak market in the bull, the third quarter last year, the rise was up to 56.38%.　　And on November 17 last year, the company announced a new type of liver cancer Licatin Fourth clinical trial results, the Chinese god Group also pulled out 5 trading board, and on November 26 reached a record 27.51 yuan. Yesterday, however, China God Group issued a bulletin said, "in combination with the current work to promote the actual situation, and then integrated the views of all parties, the conditions of the non-public offering is still uncertain, and ultimately obtain the relevant authorities to approve or approve the time is also uncertain, so the board decided to terminate the company's non-public offerings of the plan "Daily economic news" reporter noted that in the release of the plan to the end of the seven-month period, the Chinese god Group has not convened a general meeting of shareholders to consider the project.　　Although there is no provision for the issuance of additional plans after the launch of the general meeting of the time interval, but such a long delay, or make some investors feel anxious, after all, the adoption of the General Assembly is the prerequisite for regulatory approval.　　Institutions take advantage of the three quarter stock price rose away from the field what is the reason that the company finally gave up the original proposal? "Daily economic news" yesterday as an investor to call the securities department of the Chinese god Group, a staff member replied: "[Company] with some brokers, funds after the initial communication, feel that the conditions are not complete, and then obtain the approval of the authorities and approval of the time there is uncertainty."　　"From the staff's answer, you can see that the" securities, funds, "and other institutions of the company's views on the issue appears to be important.　　Interestingly, in the process of the group's 56.38% rally in the third quarter of last year, it was the institutions that profited. China God Group 2010In the two quarter of last year, the "death squads master" Xu Xiang at the helm of Ze-hee Ruijin 1th became the company's third largest circulation shareholder, Xu Dacheng management of the Bo Yi and Bo Yi 2 period is also the tenth largest, the largest circulating shareholder. In other institutions, the investment core value of the Mixed Securities Investment Fund, the broad market Growth Hybrid fund and Huatai Securities also entered the top ten circulating shareholders.　　In addition, it can be seen from the newspaper, a large number of institutional investors in late June last year, four batches to the Chinese god Group for research. But as the group surged in the third quarter of last year, the two-quarter entry agencies began to evacuate.　　In the three quarterly reports of the Chinese gods group last year, none of the previous institutions appeared. A pharmaceutical industry analyst at Xiang Fortune Securities said there were two reasons the agency did not support the issue: one was that valuations were high when the company's future growth was uncertain, and the second was the recent two-tier market slump.　　According to the 2010-2012-year forecast, the company's earnings per share of 0.04 yuan, 0.26 yuan and 0.4 yuan, calculated yesterday, the corresponding dynamic P/E ratio of up to 431 times times, 66 times times and 43 times times respectively.　　The analyst said that the company's small radiation dose Licatin is in the exploratory phase of clinical application, there is some uncertainty in the future, and the company's new drug reporting progress is not ideal. On the issue of New drug reporting, the Chinese God Group staff yesterday said to reporters, "there is no disclosure of information."　　"Simultaneous reporting of debt on the launch of the Science and Technology Park two phase of the construction of the group did not support the decision to borrow a large construction project."　　In yesterday's announcement, the company board of Directors deliberated on the motion on optimizing resource allocation, concentrating industrial development and investing in the construction of the two-phase (biological Agent workshop project and the Watson Group Pharmaceutical Project) by the vice chairman and President Zhou. China God high-tech Industrial Park biological Preparation workshop Project total investment of 64.5938 million yuan, of which construction investment of 41.92 million yuan, project investment finance internal rate of return of 32.3%,　　Static project investment recovery period of 6.86 years, dynamic investment recovery period of 8.36 years, is expected to be completed in September 2011 acceptance, December 2011 Commissioning. Hua Shen High-tech Industrial Park pharmaceutical Project Investment total of 114 million yuan, of which the construction investment of 84.3092 million yuan, the project investment finance internal rate of return of 29.17%,　　Static project investment recovery period of 6.25 years, dynamic investment recovery period of 8.52 years, is expected to be completed in September 2012 acceptance, December 2012 commissioning. The total investment of the two projects is 179 million yuan, of which the total construction investment of 126 million yuan, equipment, the old total of 20.438 million yuan, bedding liquidity total of 32.3223 million yuan.　　The funds required by the group and pharmaceutical factories, biological companies self-financing and bank financing solutions. Company staff told reporters that the new industrial park must include Licatin as well as the production line, but not with the originalConsistent in the directional additional plan. As for the 37 planting base construction and reserve project, the company has no news.